PATENT CLAIM ANALYSIS

Application Number: 16040324
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["514", "081000"]

Abstract:
The disclosure is directed to methods of treating subjects infected with HIV, once daily, with single unit dosage forms that include darunavir (or a hydrate or solvate thereof), cobicistat, emtricitabine, and a tenofovir prodrug, or salt thereof.

Claim (Index 41):
A method of making the single unit dosage form of  claim 25  comprising\n mixing\n darunavir, or a hydrate or solvate thereof; \n cobicistat; \n emtricitabine; and \n tenofovir, a tenofovir prodrug, a pharmaceutically acceptable salt of tenofovir, or a pharmaceutically acceptable salt of a tenofovir prodrug; and \n a microcrystalline cellulose and a croscarmellose sodium for a time sufficient to form a first mixture; \n \n mixing the first mixture with a first lubricant for a time sufficient to form a second mixture; \n compacting the second mixture to form a compacted mixture; \n milling the compacted mixture to form granules; \n mixing the granules with a second lubricant for a time sufficient to produce a granule mixture; \n compressing the granule mixture into one or more tablets; and \n optionally coating the one or more tablets with a coating layer.

Metadata:
- Claim Count in Document: 44.0
- Percentile: 95.0
- Lexical Diversity: 1.27778
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15913750', '14679887', '11669547', '15406344', '14747621']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.77707179082817
- 35 USC 102 Novelty (BERT): 0.5171331253650521
- Combined Prediction Score: 0.7510779242818583
- Mean Citation Score: 309.5180220000001
- Max Citation Score: 312.86664
- Similarity Product: 225.6212539772129

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test